Angiotensin II Antagonists, ACE Inhibitors

Use in Pregnancy

When used in pregnancy, drugs that act directly on the renin-angiotensin system can cause injury and even death to developing fetus.

When Pregnancy is detected, these drugs should be discontinued as soon as possible.

See Package Insert WARNINGS: Fetal/Neonatal Morbidity and Mortality

Note: Recent changes in some ACE inhibitor black boxes were introduced in 2007 per this announcement. Please check with the most current labeling for pregnancy restrictions before prescribing. When pregnancy is detected, the drug should be discontinued as soon as possible.

Medication Guides

Patient Medication Guides

Updated June 2009

Disclaimer: This information presents a SUMMARY of Black Box data from product information labeling and does not address additional warnings, precautions, or other important safety data in the product insert. Patient care decisions SHOULD NOT be made without reviewing the most recent product information insert, which may be obtained from the manufacturer. This table may not be complete as it was prepared using product information from package inserts. It is periodically updated with supplemental information from FDA safety alerts, the FDA labeling announcements, and new drug approvals.

Formweb is a product of Formulary Productions, LLC. Visit our website at www.formweb.com for more information on online formularies featuring Black Box Warnings.
901-767-3000